Completed PHASE3 INTERVENTIONAL 2-arm NCT00902330

Cranial Stimulation for Chemotherapy Symptoms in Breast Cancer

Sponsor: National Cancer Institute (NCI)

Conditions Anxiety Disorder Breast Cancer Depression Fatigue Pain Sleep Disorders

Interventions energy-based therapy sham intervention

Updated 6 times since 2017 Last updated: Nov 19, 2015 Started: Apr 30, 2009 Primary completion: May 31, 2013 Completion: May 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00902330, this PHASE3 trial focuses on Anxiety Disorder and Breast Cancer and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 6 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)
Virginia Commonwealth University

Data source: Virginia Commonwealth University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.